TREATMENT WITH INFLIXIMAB IMPROVES CLINICAL RESPONSE AND PHYSICAL FUNCTION IN PATIENTS WITH MODERATE OR SEVERE RHEUMATOID ARTHRITIS ACTIVELY SWITCHED FROM ETANERCEPT OR ADALIMUMAB THERAPY

被引:0
|
作者
Fleischmann, R. [1 ]
Goldman, J. [2 ]
Leirisalo-Repo, M. [3 ]
Zanetakis, E. [4 ]
El-Kadi, H. [5 ]
Kellner, H. [6 ]
Bolce, R. [7 ]
Wang, J. [8 ]
Dehoratius, R. [7 ]
Decktor, D. [7 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[2] Atlanta Ctr Clin Res, Atlanta, GA USA
[3] Univ Helsinki, Cent Hosp, Helsinki, Finland
[4] Oklahoma Ctr Arthrit Therapy & Res Inc, Rheumatol, Tulsa, OK USA
[5] Arthrit & Osteoporosis Associates PA, Rheumatol, Freehold, NJ USA
[6] Ctr Inflammatory Joint Dis, Munich, Germany
[7] Centocor Ortho Biotech Serv LLC, Med Affairs, Horsham, PA USA
[8] Johnson & Johnson Pharmaceut Res & Dev LLC, Clin Res, Belle Mead, NJ USA
来源
RHEUMATOLOGY | 2011年 / 50卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:114 / 115
页数:2
相关论文
共 50 条
  • [1] IMPROVED QUALITY OF LIFE AND PRODUCTIVITY IN PATIENTS WITH MODERATE OR SEVERE RHEUMATOID ARTHRITIS ACTIVELY SWITCHED TO TREATMENT WITH INFLIXIMAB FROM ADALIMUMAB OR ETANERCEPT THERAPY
    Fleischmann, Roy
    Bolce, Rebecca
    Wang, Jianping
    Ingham, Mike
    Dehoratius, Ralph
    Decktor, Dennis
    [J]. RHEUMATOLOGY, 2012, 51 : 138 - 138
  • [2] Improved Quality of Life and Productivity in Patients with Moderate or Severe Rheumatoid Arthritis Actively Switched to Treatment with Infliximab From Adalimumab or Etanercept Therapy.
    Fleischmann, Roy M.
    Bolce, Rebecca
    Wang, Jim
    Ingham, Mike
    DeHoratius, Raphael J.
    Decktor, Dennis
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S865 - S865
  • [3] Therapy of patients with rheumatoid arthritis: Outcome of infliximab failures switched to etanercept
    Buch, Maya H.
    Bingham, Sarah J.
    Bejarano, Victoria
    Bryer, Domini
    White, Jo
    Emery, Paul
    Reece, Richard
    Quinn, Mark
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (03): : 448 - 453
  • [4] Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy
    Gómez-Puerta, JA
    Sanmartí, R
    Rodríguez-Cros, JR
    Cañete, JD
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (07) : 896 - 896
  • [5] The drug survival of adalimumab compared to etanercept and infliximab in treatment of patients with rheumatoid arthritis in daily clinical practice
    Kievit, W.
    Fransen, J.
    Kupper, H. H.
    Van de Laar, M. A. F. J.
    De Rooij, D. J. R. A.
    De Gendt, C. M.
    Jansen, T. L.
    Ronday, K. H.
    Bruse, H. L. C.
    Moolenburgh, J. D.
    Janson, M.
    Van Oijen, P. C. M.
    Adang, E. M.
    Van Riel, P. L. C. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 325 - 325
  • [6] Treatment with etanercept or infliximab improves hand function in patients with long-standing rheumatoid arthritis
    Sandqvist, Gunnel
    Saxne, Tore
    Geborek, Pierre
    [J]. RHEUMATOLOGY, 2001, 40 : 32 - 32
  • [7] Adalimumab in rheumatoid arthritis after failed infliximab and/or etanercept therapy: experience with 18 patients
    Brocq, O
    Albert, C
    Roux, C
    Gerard, D
    Breuil, V
    Ziegler, LE
    [J]. JOINT BONE SPINE, 2004, 71 (06) : 601 - 603
  • [8] Patient-Reported Outcomes for Etanercept Therapy in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment
    Bessette, Louis
    Khraishi, Majed
    Kivitz, Alan J.
    Kaliyaperumal, Arunan
    Grantab, Rama
    Poulin-Costello, Melanie
    Isaila, Maya
    Collier, David
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [9] Patient-Reported Outcomes for Etanercept Therapy in Adult Patients with Moderate to Severe Rheumatoid Arthritis who Failed Adalimumab Treatment
    Khraishi, Majed
    Bessette, Louis
    Kivitz, Alan
    Kaliyaperumal, Arunan
    Grantab, Rana
    Poulin-Costello, Melanie
    Isaila, Maya
    Collier, David
    [J]. JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 947 - 947
  • [10] Short-term adalimumab therapy improves endothelial function in patients with rheumatoid arthritis refractory to infliximab
    Gonzalez-Juanatey, C.
    Llorca, J.
    Sanchez Andrade, A.
    Garcia-Porrua, C.
    Martin, J.
    Gonzalez-Gay, M. A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (03) : 309 - 312